4/A

PRIMARY DOCUMENT

Company: UNITED THERAPEUTICS Corp
Filed: March 7, 2017
Period of Report: June 21, 2016
Accession Number: 0001127602-17-010634

View Document ↗ View on SEC.gov ↗